CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke
Jay Chol Choi, Ji Sung Lee, Tai Hwan Park, Sang-Soon Park, Yong-Jin Cho, Jong-Moo Park, Kyusik Kang, Kyung Bok Lee, Soo-Joo Lee, Youngchai Ko, Jae Guk Kim, Jun Lee, Ki-Hyun Cho, Joon-Tae Kim, Kyung-Ho Yu, Byung-Chul Lee, Mi-Sun Oh, Jae-Kwan Cha, Dae-Hyun Kim, Hyun-Wook Nah, Dong-Eog Kim, Wi-Sun Ryu, Beom Joon Kim, Hee-Joon Bae, Wook-Joo Kim, Dong-Ick Shin, Min-Ju Yeo, Sung Il Sohn, Jeong-Ho Hong, Juneyoung Lee, Keun-Sik Hong
J Stroke. 2015;17(3):327-335.   Published online September 30, 2015
DOI: https://doi.org/10.5853/jos.2015.17.3.327

Excel Download

Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke
The Journal of Emergency Medicine. 2013;45(5):810   Crossref logo
Link1 Link2

Influences of Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator on the Outcome of Atrial Fibrillation Patients with Acute Ischemic Stroke: A Case a Case-control Study of 227 Patients
. 2021;   Crossref logo
Link1 Link2

Outcome of intravenous recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke in Thailand
Journal of Stroke and Cerebrovascular Diseases. 2017;26(4):897   Crossref logo
Link1 Link2

Consensus Statement on the Use of Intravenous Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke by the Chinese Stroke Therapy Expert Panel
CNS Neuroscience & Therapeutics. 2013;19(8):543-548   Crossref logo
Link1 Link2

0058 Circadian Variation Of The Efficacy Of Intravenous Recombinant Tissue Plasminogen Activator In Patients With Acute Ischemic Stroke
Sleep. 2018;41(suppl_1):A23-A24   Crossref logo
Link1

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years
Geriatrics & Gerontology International. 2015;16(7):843-849   Crossref logo
Link1 Link2

Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study
Cerebrovascular Diseases. 2016;42(1-2):41-48   Crossref logo
Link1 Link2

Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Yearbook of Neurology and Neurosurgery. 2011;2011:10-11   Crossref logo
Link1 Link2

Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients
Journal of Stroke and Cerebrovascular Diseases. 2016;25(7):1823-1827   Crossref logo
Link1 Link2

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients
Yearbook of Neurology and Neurosurgery. 2007;2007:15-17   Crossref logo
Link1 Link2